Defunct Company
Total Trials
20
As Lead Sponsor
13
As Collaborator
7
Total Enrollment
4,451
NCT00146211
TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease
Phase: Phase 3
Role: Lead Sponsor
Start: Sep 30, 2005
Completion: Jul 31, 2007
NCT01846247
A Very Early Rehabilitation Trial
Phase: N/A
Start: Jun 30, 2006
Completion: Jan 31, 2015
NCT00887328
Extending the Time for Thrombolysis in Emergency Neurological Deficits
Start: Jun 30, 2010
Completion: Aug 27, 2018
NCT01492725
Extending the Time for Thrombolysis in Emergency Neurological Deficits - Intra-Arterial
Phase: Phase 2
Start: Jun 30, 2012
Completion: Dec 31, 2014
NCT01580839
EXTEND (International): Extending the Time for Thrombolysis in Emergency Neurological Deficits (International)
Start: Dec 6, 2012
Completion: Aug 22, 2018
NCT01702636
STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial
Start: Dec 31, 2012
Completion: Dec 31, 2019
NCT02388061
Tenecteplase Versus Alteplase Before Endovascular Therapy for Ischemic Stroke
Start: Mar 23, 2015
Completion: Feb 28, 2018
NCT02899611
A Dose Ranging Pilot Study for Intracerebroventricular (ICV) Delivery of Valproate in Subjects With Temporal Seizures
Phase: Phase 1/2
Role: Collaborator
Start: Aug 31, 2016
Completion: Jun 1, 2021
NCT02868580
Safety and Tolerability of Antiretroviral (Triumeq) in Patients With Amyotrophic Lateral Sclerosis (ALS).
Start: Oct 31, 2016
Completion: Dec 31, 2018
NCT03287076
Trial of EXenatide in Acute Ischaemic Stroke
Start: Nov 23, 2017
Completion: Dec 31, 2021
NCT03340493
Determining the Optimal Dose of Tenecteplase Before Endovascular Therapy for Ischaemic Stroke (EXTEND-IA TNK Part 2)
Start: Dec 6, 2017
Completion: Feb 1, 2020
NCT03234686
Deferiprone to Delay Dementia (The 3D Study)
Start: Jan 19, 2018
Completion: Feb 23, 2023
NCT03385928
STOP-MSU: Stopping Haemorrhage With Tranexamic Acid for Hyperacute Onset Presentation Including Mobile Stroke Units
Start: Mar 19, 2018
Completion: May 28, 2023
NCT03944460
SAD Phase I Study (First-in-human) to Investigate Contraloid Acetate
Phase: Phase 1
Start: Apr 9, 2018
Completion: Jul 27, 2018
NCT03494920
DIRECT-SAFE: A Randomized Controlled Trial of DIRECT Endovascular Clot Retrieval Versus Standard Bridging Thrombolysis With Endovascular Clot Retrieval
Start: Apr 27, 2018
Completion: Sep 8, 2021
NCT03955380
MAD Phase I Study to Investigate Contraloid Acetate
Start: Dec 12, 2018
Completion: Apr 3, 2019
NCT04776031
Evaluation of R:GEN as Intervention in Subjects With Early Stages of AMD for Safety and Exploratory Efficacy Outcomes
Start: Feb 15, 2021
Completion: Mar 14, 2023
NCT04759365
Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of Oral ASN51 in Healthy Subjects and Subjects With Alzheimer's Disease
Start: Jun 2, 2021
Completion: Aug 1, 2022
NCT05070702
First in Human Study of CT-1500 in Healthy Participants
Start: Nov 8, 2021
Completion: Jul 7, 2022
NCT05363397
Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke
Start: Sep 27, 2023
Completion: May 1, 2026